BBBirgit H. B. van Benthem

Birgit H. B. van Benthem

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Birgit H. B. van Benthem has a total of 244 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Increased HIV Incidence during Event-Driven PrEP Compared to Daily PrEP in the Netherlands

    by Inge Willemstein, Maria Prins, Janneke Heijne, Udi Davidovich, Maarten F. Schim van der Loeff, Linda Ernestina Chanamé Pinedo, Eddymurphy Akwiwu, Birgit B.H.B. van Benthem, Elske Hoornenborg, Vita W. Jongen

    Background: Clinical trials demonstrated high efficacy of daily and event-driven oral pre-exposure prophylaxis (PrEP) in HIV prevention. Event-driven PrEP involves taking two tablets before and two times one tablet after sexual contact (2-1-1/on-demand). While both are implemented in Dutch clinical practice, evaluating real-world effectiveness requires large-scale data from routine clinical care. This study compared HIV incidence between daily and event-driven PrEP in the Netherlands.Methods: We used surveillance data from the Dutch national PrEP program (August 1, 2019-December 31, 2025). Individuals ≥16 years with ≥1 follow-up consultation after PrEP initiation were included; PrEP regimen since last visit was recorded at each visit. Person-time was modeled as time-varying based on the regimen reported at each consultation. HIV incidence rates were calculated per 100 person-years and Cox proportional hazards models estimated hazard ratios between regimens for HIV acquisition, adjusted for sociodemographics, sexual behavior, and history of sexually transmissible infections.Findings: 16,469 individuals (15,843 men who have sex with men, 579 transgender and gender diverse persons, 45 women and two men who have sex with women) initiated PrEP and had ≥1 follow-up visit (median follow-up 2·0 years (IQR=0·8-4·0)). Median age was 33 years (IQR=27-44). 49 PrEP users were diagnosed with HIV over 41,092 person-years (IR=0·12/100 py;95%CI=0·09-0·16), of whom 42 event-driven users (IR=0·20/100 py;95%CI=0·15-0·27) and seven daily PrEP users (IR=0·04/100 py;95%CI=0·02-0·07). In multivariable Cox regression, event-driven PrEP use was associated with a higher hazard of HIV acquisition (aHR=7·0;95%CI=3·0-16·4).Interpretation: Despite overall low HIV incidence, the incidence rate in the Dutch national PrEP program was seven-fold higher during event-driven PrEP use compared to daily, which may be due to lower adherence. These findings denotes that, in real-world settings, improved person-centered counseling is needed for individuals interested in, or using event-driven PrEP. Research should identify domains and preferred methods of support.

  • Open Access

    Lost and Not Found: Determinants and Patterns of Loss to Follow-Up Among Men Who Have Sex With Men in the Dutch HIV Pre-Exposure Prophylaxis Pilot Program

    by Daphne A. van Wees, Danja Sarink, Birgit H.B. van Benthem, Karlijn Kampman, Colette van Bokhoven, Fleur van Aar

    Introduction: One of the challenges of a national HIV pre-exposure prophylaxis (PrEP) program is continuation of PrEP use and retention in care. The aim of this study was to explore determinants of loss to follow-up (LTFU) among men who have sex with men (MSM) in the Dutch national PrEP pilot program. Methods: Data from the national STI surveillance database between July 1, 2019, and December 31, 2022, were used of all 3-monthly PrEP pilot consultations among MSM who had at least 2 consultations. LTFU was defined as having no consultation for ≥7 months, and was further divided into “missed consultation/restarted” and “definitive LTFU.” We used mutually adjusted, multivariable, multistate, time-homogenous Markov models to analyze demographic and behavioral associations with LTFU. Results: A total of 8948 participants (62,158 consultations) were included, of which 30% were LTFU at some point. Young participants and on-demand/nonrecent PrEP users (ie, in the past 3 months) were more likely to become LTFU. Participants who had ≥6 partners (vs 0–2) in the past 6 months or were ≥25 years of age (vs <25) were less likely to become LTFU. In addition, non-Dutch origin was associated with missed consultation/restarted and definitive LTFU. Furthermore, having had no (condomless) anal sex in the past 6 months was associated with missed consultation/restarted. Conclusions: Specific characteristics of MSM who were LTFU, such as young age, non-Dutch origin, and on-demand PrEP use, may be used to implement targeted interventions to increase PrEP retention and possibly prevent new HIV infections among PrEP users.


  • Open Access

    Combining mpox vaccination and behavioural changes to control possible future mpox resurgence among men who have sex with men: a mathematical modelling study

    by Maria Xiridou, Daphne Amanda van Wees, Philippe Christian Guy Adam, Fuminari Miura, Eline Op de Coul, Maarten Reitsema, John B.F. de Wit, Birgit van Benthem, Jacco Wallinga

    Introduction: The 2022 outbreak of mpox subclade IIb in the Netherlands affected primarily men who have sex with men (MSM). Despite the sharp decline in cases, there are concerns about future mpox outbreaks. We investigated the impact of mpox introductions, accounting for vaccination, behavioural changes, and introductions of subclades with different characteristics. Methods: We developed a compartmental model for mpox among MSM. We distinguished three levels of sexual activity: low, medium, and high. The group with high activity was the 5% of the population with the highest numbers of sexual partners; the group with low activity was the 60% with the lowest numbers of partners. In the model, individuals were allowed to change sexual activity level. We examined several scenarios with mpox introductions. Results: In January 2024, 54% of MSM with high sexual activity level had immunity; this declined to 39% a year later, due to changes in sexual activity. Introduction of 5 cases in May 2025 resulted in 759 cases in the first four months without vaccination after 2023, but the numbers of cases were 34% or 48% lower with 3,000 vaccinations in August-October 2024 or February-April 2025, respectively. With earlier initiation or greater magnitude of behavioural adaptations, the number of mpox cases was 17-51% smaller. Introduction of a subclade with 10% higher transmission probability than subclade IIb resulted in 77% more cases. Conclusions: Due to changes in sexual activity, the fraction immune in the group with high sexual activity will decline, leading to greater possibilities for future mpox outbreaks. The number of cases can be reduced with preventive vaccination and behavioural adaptations. Recurring vaccination campaigns should prioritise individuals with high sexual activity level, ensuring those entering high-activity groups are reached. Campaigns promoting timely behavioural changes remain crucial. KEY MESSAGES: What is already known on this topic: The numbers of mpox cases among men who have sex with men (MSM) in the Netherlands were low in 2023-2024, but there have been many introductions of new cases infected outside the Netherlands. Therefore, there are concerns about future mpox outbreaks, but it is uncertain whether new mpox vaccination campaigns are needed. What this study adds: Due to behavioural changes, not-immune MSM enter the group with high sexual activity, thus reducing the fraction immune within the group and increasing the possibility of future mpox outbreaks. Preventive mpox vaccination and behavioural adaptations can impede mpox spread. However, outbreak sizes will increase as the time between vaccination roll-out and new introductions is extended. How this study might affect research, practice or policy: Social marketing and interventions promoting timely behavioural changes and vaccination are essential. Recurring vaccination campaigns are necessary for mpox prevention, prioritising individuals with high sexual activity level and ensuring those entering high-activity groups are reached. The findings also emphasize that research is needed to understand determinants of behaviour and monitor behavioural changes over time.


  • Open Access

    Impact of Varying Pre-exposure Prophylaxis Programs on HIV and Neisseria gonorrhoeae Transmission Among MSM in the Netherlands: A Modeling Study

    by Maarten Reitsema, Jacco Wallinga, Ard I. van Sighem, Daniela Bezemer, Marc van der Valk, Fleur van Aar, Janneke Cornelia Maria Heijne, Elske Hoornenborg, Ganna Rozhnova, Birgit van Benthem, et al.

    Background: In 2019, a 5-year pre-exposure prophylaxis (PrEP) program started in the Netherlands, in which up to 8500 men who have sex with men (MSM) can obtain PrEP and 3-monthly consultations with HIV/STI testing. Setting: We assessed the impact of the PrEP program on transmission of HIV and Neisseria gonorrhea (NG) among MSM in the Netherlands and examined prospective variations of the program after 2024. Methods: We used an agent-based model to estimate the effect of the PrEP program. For hypothetical prospective PrEP programs starting in 2024, we varied the capacity (8,500; 12,000; 16,000 participants) and consultation frequency (3-monthly; 6-monthly; 70% 3-monthly and 30% 6-monthly). Results: At a capacity of 8,500 participants and 3-monthly consultations, the PrEP program could lead to 3,140 [95% credible interval (95% CrI): 1,780–4,780] and 27,930 (95% CrI: 14,560–46,280) averted HIV and NG infections, requiring 316,050 (95% CrI: 314,120–317,580) consultations. At a capacity of 16,000 participants, the programs with 3-monthly consultations and 6-monthly consultations could lead to comparable number of averted HIV [3,940 (95% CrI: 2,420–5,460), and 3,900 (2,320–5,630) respectively] and NG infections [29,970 (95% CrI: 15,490–50,350), and 29,960 (95% CrI: 13,610–50,620) respectively], while requiring substantially different number of consultations: 589,330 (95% CrI: 586,240–591,160) and 272,590 (95% CrI: 271,770–273,290), respectively. Conclusions: Continuation of a PrEP program could lead to a substantial reduction in HIV and NG transmission. More infections could be averted if the number of participants is increased. In turn, the consultation frequency could be reduced without reducing the number of averted infections if capacity is increased.


  • Open Access

    Oral HIV pre-exposure prophylaxis use and resistance-associated mutations among men who have sex with men and transgender persons newly diagnosed with HIV in the Netherlands: results from the ATHENA cohort, 2018 to 2022

    by Vita W Jongen, Daniela Bezemer, Ard van Sighem, Anders Boyd, Casper Rokx, Karin Grintjes, Aafke Cents-Bosma, Eline Op de Coul, Birgit van Benthem, Annemarie Wensing, et al.

    Background: In the Netherlands, HIV pre-exposure prophylaxis (PrEP) has been available since 2019. However, the extent of PrEP use prior to HIV diagnosis and development of PrEP-resistance-associated mutations (RAMs) is not known. Aim: We assessed prior PrEP use and potential transmission of PrEP RAMs among men who have sex with men (MSM) and transgender persons (TGP) with a new HIV diagnosis in the Netherlands. Methods: Data on prior PrEP use between 1 January 2018 and 31 December 2022 were available from the Dutch national ATHENA cohort. We assessed proportion of prior PrEP use, detected PrEP associated RAMs and assessed potential onward transmission of RAMs between 2010 and 2022 using a maximum likelihood tree. Results: Data on prior PrEP use were available for 583/1,552 (36.3%) individuals, with 16% (94/583) reporting prior PrEP use. In 489 individuals reporting no prior PrEP use, 51.5% did not use PrEP due to: low HIV-risk perception (29%), no access (19.1%), personal preference (13.1%), and being unaware of PrEP (19.1%). For PrEP users, 13/94 (13.8%) harboured a M184V/I mutation, of whom two also harboured a K65R mutation. In people with a recent HIV infection, detection of PrEP RAMs increased from 0.23% (2/862) before 2019 to 4.11% (9/219) from 2019. We found no evidence of onward transmission of PrEP RAMs. Conclusion: The prevalence of PrEP-associated RAMs has increased since PrEP became available in the Netherlands. More widespread access to PrEP and retaining people in PrEP programmes when still at substantial risk is crucial to preventing new HIV infections.


  • Open Access

    Changes in Genital Human Papillomavirus (HPV) Prevalence During 12 Years of Girls-Only Bivalent HPV Vaccination: Results From a Biennial Repeated Cross-sectional Study

    by Johannes M A Kusters, Maarten F Schim van der Loeff, Janneke C M Heijne, Audrey J King, Hester E de Melker, Titia Heijman, Johannes A Bogaards, Birgit H B van Benthem, for the Papillomavirus Surveillance Among STI Clinic Youngsters in the Netherlands (PASSYON) Study Group, Helmie van der Meijden, et al.

    From 2009 until 2021, bivalent HPV vaccination was offered only to girls in the Netherlands. We aimed to study the impact of girls-only HPV vaccination on genital HPV prevalence among young adults. PASSYON is a biennial repeated cross-sectional study (2009-21) among sexual health clinic clients aged 16-24 years old. Questionnaires elicited data on demographics, sexual behaviour and HPV vaccination status. Genital samples were collected and analysed using a PCR-based assay (SPF10-LiPA25). Type-specific prevalence trends of 12 high-risk (hr) genotypes were analysed as the adjusted average annual change (aAAC), estimated using Poisson GEE models. The relation between aAAC and phylogenetic distance to HPV-16/18 was assessed by means of regression and rank correlation analysis. Questionnaires and genital samples were collected from 8,889 females and 3,300 heterosexual males (HM). 4,829 females reported to be unvaccinated (54·3%). Among females (irrespective of vaccination status), prevalences of HPV-16/18/31/33/35/45 decreased significantly over time. Increasing trends were observed for HPV-39/52/56. Among both HM and unvaccinated females HPV-16/18 prevalence significantly declined, as did HPV-31 among HM. In contrast, HPV-52/58 increased significantly among HM and unvaccinated females. The type-specific aAAC correlated well with the phylogenetic distance to HPV-16/18. During twelve years girls-only bivalent HPV vaccination in the Netherlands, decreasing trends of the vaccine types and cross-protected types were observed among females. Herd protection of vaccine-types was observed for HM and unvaccinated females, and one cross-protected type for HM. Increasing prevalence trends of HPV types with large phylogenetic distance to the vaccine types might indicate type-replacement.


  • Open Access

    Effects of Improved Partner Notification on the Transmission of HIV and N. Gonorrhoea Among Men Who Have Sex With Men: A Modelling Study

    by Maarten Reitsema, Jacco Wallinga, Birgit van Benthem, Eline Op de Coul, Ard van Sighem, Maarten Schim van der Loeff, Maria Xiridou

    Men who have sex with men (MSM) are disproportionally affected by HIV in the Netherlands. Partner Notification (PN) is an important element of controlling the transmission of sexually transmitted infections (STIs) and HIV. We investigated the effects of improving PN on the transmission of HIV and N. gonorrhoeae (NG) among MSM in the Netherlands. We developed an agent-based model that describes the transmission of HIV and NG among MSM. In the baseline scenario 14.3% and 29.8% of casual and steady partners of the index case get notified and tested for HIV/STI after three weeks (percentage notified and tested, PNT). We examined the following scenarios: 1) Increase PNT to 41% for both partner types; 2) Decrease the time between index and the partners tested to one week; 3) Combine scenario 1 and 2. Effects are expressed as cumulative change from the baseline simulation over 15 years. Increasing PNT could lead to a decrease in gonorrhea cases of 45% (IQR: 39.9 – 49.9%), with an increase in number of HIV/STI tests of 4.4% (IQR: 1.6 – 7.3%), but no change in HIV infections (−5.4%; IQR: -21 – 7.9%). Decreasing time between tests could lead to a change in new NG infections of -14.2% (IQR: -17.2 – -10%), no change in HIV infections (8.2%; IQR: - 1.3 – 20%) or in number of HIV/STI tests performed (−0.4%; IQR: - 1.5 – 0.6%). Scenario 3 led to a change in NG infections of -56.8% (IQR: - 63.8 – - 47.4%), no change in HIV infections (11.5%; IQR: -11.1 – 33.9%) or in number of HIV/STI tests (− 0.5%; IQR: - 4.9 – 4.3%). Increasing the percentage of sexual partners notified and tested for HIV/STI may have only a small effect on HIV, but could reduce the number of new NG infections substantially. However, it could lead to an increase in the number of HIV/STI tests performed. Key messages What is already known on this topic: Notifying recent sexual partners of people diagnosed with HIV or other sexually transmitted infections (STI) can promote timely testing and early treatment, thereby reducing further transmission of STIs What this study adds: We quantify the effects of improving partner notification on the transmission of two STIs simultaneously. How this study might affect research, practice or policy: In our scenarios, increasing the percentage of partners who get notified and tested had a bigger impact than decreasing the time between testing the index and his partners.

  • Open Access

    The association between viral load and concurrent human papillomavirus infection at the genital and anal sites of young women and the impact of vaccination

    by Kahren van Eer, Ihsane Laâbi, Birgit H.B. van Benthem, Renske D.M. Steenbergen, Audrey J. King, D. Adema, R. Buist-Arkema, A. Beerens, D. Luijt, S. Meijer, et al.


  • Open Access

    Chlamydia trachomatis, Neisseria gonorrhoea, and Trichomonas vaginalis infections among pregnant women and male partners in Dutch midwifery practices: prevalence, risk factors, and perinatal outcomes

    by Eline L. M. Op de Coul, Demi Peek, Yolanda W. M. van Weert, Servaas A. Morré, Ingrid Rours, Chantal Hukkelhoven, Ank de Jonge, Birgit van Benthem, Monique Pereboom

    Background: Antenatal screening for HIV, syphilis and HBV has been successfully implemented in The Netherlands, but data on other STI among pregnant women or male partners are limited. Our objectives: (i) to assess the prevalence of Chlamydia trachomatis (CT), Neisseria gonorrhoeae (NG) and Trichomonas vaginalis (TV) among pregnant women and male partners, (ii) to identify risk factors for these STI during pregnancy, and (iii) to identify adverse perinatal outcomes (APO) associated with STI. Methods: Cross-sectional study. Pregnant women aged ≤ 30 years (n = 548) and male partners (n = 425) were included at 30 midwifery practices during 2012–2016. Participants provided a self-collected vaginal swab (women) or urine sample (men) and completed a questionnaire. Perinatal data were derived from pregnancy cards. APO was defined as premature rupture of membranes, preterm delivery, low birthweight, stillbirth, neonatal conjunctival and respiratory infections. Data were analysed by logistic regression. Results: STI were present in 2.4% of pregnant women (CT 1.8%, NG 0.4%, TV 0.4%), and in 2.2% of male partners (CT 2.2%, NG 0.2%, TV 0%). Of young women (≤ 20 years), 12.5% had a CT infection. Prevalent STI during pregnancy was associated with female young age (≤ 20 years vs ≥ 21 years) (adjusted OR 6.52, CI 95%: 1.11–38.33), male non-Western vs Western background (aOR 9.34, CI 2.34–37.21), and female with ≥ 2 sex partners < 12 months vs 0–1 (aOR 9.88, CI 2.08–46.91). APO was not associated with STI, but was associated with female low education (aOR 3.36, CI 1.12–10.09), complications with previous newborn (aOR 10.49, CI 3.21–34.25 vs no complications) and short duration (0–4 years) of relationship (aOR 2.75, CI 1.41–5.39 vs ≥ 5 years). Small-for-gestational-age was not associated with STI, but was associated with female low education (aOR 7.81, 2.01–30.27), female non-Western background (aOR 4.41, 1.74–11.17), and both parents smoking during pregnancy (aOR 2.94, 1.01–8.84 vs both non-smoking). Conclusions: Prevalence of STI was low among pregnant women and male partners in midwifery practices, except for CT among young women. The study could not confirm previously observed associations between STI and APO, which is probably due to low prevalence of STI, small study sample, and presumed treatment for STI.


  • Open Access

    Can Previous Associations of Single Nucleotide Polymorphisms in the TLR2, NOD1, CXCR5, and IL10 Genes in the Susceptibility to and Severity of Chlamydia trachomatis Infections Be Confirmed?

    by Jelmer B. Jukema, Bernice M. Hoenderboom, Birgit H. B. van Benthem, Marianne A. B. van der Sande, Henry J. C. de Vries, Christian J. P. A. Hoebe, Nicole H. T. M. Dukers-Muijrers, Caroline J. Bax, Servaas A. Morré, Sander Ouburg

    Clear inter-individual differences exist in the response to C. trachomatis (CT) infections and reproductive tract complications in women. Host genetic variation like single nucleotide polymorphisms (SNPs) have been associated with differences in response to CT infection, and SNPs might be used as a genetic component in a tubal-pathology predicting algorithm. Our aim was to confirm the role of four genes by investigating proven associated SNPs in the susceptibility and severity of a CT infection. A total of 1201 women from five cohorts were genotyped and analyzed for TLR2 + 2477 G > A, NOD1 + 32656 T −> GG, CXCR5 + 10950 T > C, and IL10 − 1082 A > G. Results confirmed that NOD1 + 32656 T −>GG was associated with an increased risk of a symptomatic CT infection (OR: 1.9, 95%CI: 1.1–3.4, p = 0.02), but we did not observe an association with late complications. IL10 − 1082 A > G appeared to increase the risk of late complications (i.e., ectopic pregnancy/tubal factor infertility) following a CT infection (OR = 2.8, 95%CI: 1.1–7.1, p = 0.02). Other associations were not found. Confirmatory studies are important, and large cohorts are warranted to further investigate SNPs’ role in the susceptibility and severity of a CT infection.